Skip to main content
Top
Published in: Alzheimer's Research & Therapy 1/2015

Open Access 01-12-2015 | Review

Lung disease as a determinant of cognitive decline and dementia

Author: James W Dodd

Published in: Alzheimer's Research & Therapy | Issue 1/2015

Login to get access

Abstract

Almost 40 million people currently live with dementia but this is estimated to double over the next 20 years; despite this, research identifying modifiable risk factors is scarce. There is increasing evidence that cognitive impairment is more frequent in those with chronic lung disease than those without. Chronic obstructive pulmonary disease affects 210 million people, with cognitive impairment present in 60% of certain populations. Co-morbid cognitive dysfunction also appears to impact on important outcomes such as quality of life, hospitalisation and survival. This review summarises the evidence of an association between cognition, impaired lung function and obstructive lung disease. It goes on to examine the contribution of neuro-imaging to our understanding of the underlying pathophysiology. While the mechanisms of brain pathology and cognitive impairment are likely to be complex and multi-factorial, there is evidence to suggest a key role for occult cerebrovascular damage independent of traditional vascular risk factors, including smoking.
Literature
1.
go back to reference Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59–66.CrossRefPubMed Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59–66.CrossRefPubMed
2.
go back to reference Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scand. 2009;119:252–65.CrossRef Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scand. 2009;119:252–65.CrossRef
3.
go back to reference Stephan BC, Brayne C, Savva GM, Matthews FE. Medical Research Council Cognitive Function and Ageing Study, Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing. 2011;40:501–7.CrossRefPubMedCentralPubMed Stephan BC, Brayne C, Savva GM, Matthews FE. Medical Research Council Cognitive Function and Ageing Study, Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing. 2011;40:501–7.CrossRefPubMedCentralPubMed
5.
go back to reference Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Neurol. 2011;18:888–98.CrossRefPubMedCentralPubMed Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Neurol. 2011;18:888–98.CrossRefPubMedCentralPubMed
6.
go back to reference Weuve J, Glymour MM, Hu H, Sparrow D, Spiro 3rd A, Vokonas PS, et al. Forced expiratory volume in 1 second and cognitive aging in men. J Am Geriatr Soc. 2011;59:1283–92.CrossRefPubMedCentralPubMed Weuve J, Glymour MM, Hu H, Sparrow D, Spiro 3rd A, Vokonas PS, et al. Forced expiratory volume in 1 second and cognitive aging in men. J Am Geriatr Soc. 2011;59:1283–92.CrossRefPubMedCentralPubMed
7.
go back to reference Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosomatic Med. 2005;67:602–8.CrossRef Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosomatic Med. 2005;67:602–8.CrossRef
8.
go back to reference Vidal JS, Aspelund T, Jonsdottir MK, Jonsson PV, Harris TB, Lopez OL, et al. Pulmonary function impairment may be an early risk factor for late-life cognitive impairment. J Am Geriatr Soc. 2013;61:79–83.CrossRefPubMedCentralPubMed Vidal JS, Aspelund T, Jonsdottir MK, Jonsson PV, Harris TB, Lopez OL, et al. Pulmonary function impairment may be an early risk factor for late-life cognitive impairment. J Am Geriatr Soc. 2013;61:79–83.CrossRefPubMedCentralPubMed
9.
go back to reference Carroll D, Batty GD, Mortensen LH, Deary IJ, Phillips AC. Low cognitive ability in early adulthood is associated with reduced lung function in middle age: the Vietnam experience study. Thorax. 2011;66:884–8.CrossRefPubMed Carroll D, Batty GD, Mortensen LH, Deary IJ, Phillips AC. Low cognitive ability in early adulthood is associated with reduced lung function in middle age: the Vietnam experience study. Thorax. 2011;66:884–8.CrossRefPubMed
10.
go back to reference Anstey KJ, Windsor TD, Jorm AF, Christensen H, Rodgers B. Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004;50:230–4.CrossRefPubMed Anstey KJ, Windsor TD, Jorm AF, Christensen H, Rodgers B. Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004;50:230–4.CrossRefPubMed
11.
go back to reference Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what? Clin Respir J. 2012;6:208–14.CrossRefPubMed Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what? Clin Respir J. 2012;6:208–14.CrossRefPubMed
12.
go back to reference National Collaborating Centre for Acute and Chronic Conditions. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). National Institute for Health and Clinical Excellence (NICE). 2010. http://www.nice.org.uk/guidance/CG101. Accessed 9 February 2015. National Collaborating Centre for Acute and Chronic Conditions. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). National Institute for Health and Clinical Excellence (NICE). 2010. http://​www.​nice.​org.​uk/​guidance/​CG101. Accessed 9 February 2015.
13.
go back to reference Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1, The Lung Health Study. JAMA. 1994;272:1497–505.CrossRefPubMed Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1, The Lung Health Study. JAMA. 1994;272:1497–505.CrossRefPubMed
14.
go back to reference Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675–9.CrossRefPubMed Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675–9.CrossRefPubMed
15.
go back to reference Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma P, The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469–78.CrossRefPubMed Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma P, The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469–78.CrossRefPubMed
16.
go back to reference Bender BG, Annett RD. Neuropsychological outcomes of nocturnal asthma. Chronobiol Int. 1999;16:695–710.CrossRefPubMed Bender BG, Annett RD. Neuropsychological outcomes of nocturnal asthma. Chronobiol Int. 1999;16:695–710.CrossRefPubMed
17.
go back to reference Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy. J Asthma. 2010;47:1148–52.CrossRefPubMed Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy. J Asthma. 2010;47:1148–52.CrossRefPubMed
18.
go back to reference Brown ES, Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55:538–45.CrossRefPubMed Brown ES, Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55:538–45.CrossRefPubMed
19.
go back to reference Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES. Relationship between asthma and cognition: the Cooper Center Longitudinal Study. Allergy. 2013;68:545–8.CrossRefPubMed Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES. Relationship between asthma and cognition: the Cooper Center Longitudinal Study. Allergy. 2013;68:545–8.CrossRefPubMed
20.
go back to reference Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord. 2008;25:148–56.CrossRefPubMed Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord. 2008;25:148–56.CrossRefPubMed
21.
go back to reference Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax. 1991;46:569–73.CrossRefPubMedCentralPubMed Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax. 1991;46:569–73.CrossRefPubMedCentralPubMed
22.
go back to reference Furukawa CT, DuHamel TR, Weimer L, Shapiro GG, Pierson WE, Bierman CW. Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 1988;81:83–8.CrossRefPubMed Furukawa CT, DuHamel TR, Weimer L, Shapiro GG, Pierson WE, Bierman CW. Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 1988;81:83–8.CrossRefPubMed
23.
go back to reference Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013;10:549–55.CrossRefPubMed Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013;10:549–55.CrossRefPubMed
24.
go back to reference Weersink EJ, van Zomeren EH, Koeter GH, Postma DS. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med. 1997;156:1144–50.CrossRefPubMed Weersink EJ, van Zomeren EH, Koeter GH, Postma DS. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med. 1997;156:1144–50.CrossRefPubMed
25.
go back to reference Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of dementia among patients with asthma: a nationwide longitudinal study. J Am Med Dir Assoc. 2014;15:763–7.CrossRefPubMed Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of dementia among patients with asthma: a nationwide longitudinal study. J Am Med Dir Assoc. 2014;15:763–7.CrossRefPubMed
26.
go back to reference Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma increases dementia risk: a nationwide cohort study. J Epidemiol Community Health. 2014;69:123–8.CrossRefPubMed Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma increases dementia risk: a nationwide cohort study. J Epidemiol Community Health. 2014;69:123–8.CrossRefPubMed
27.
go back to reference Annett RD, Aylward EH, Lapidus J, Bender BG, DuHamel T. Neurocognitive functioning in children with mild and moderate asthma in the childhood asthma management program, The Childhood Asthma Management Program (CAMP) Research Group. J Allergy Clin Immunol. 2000;105:717–24.CrossRefPubMed Annett RD, Aylward EH, Lapidus J, Bender BG, DuHamel T. Neurocognitive functioning in children with mild and moderate asthma in the childhood asthma management program, The Childhood Asthma Management Program (CAMP) Research Group. J Allergy Clin Immunol. 2000;105:717–24.CrossRefPubMed
28.
go back to reference Bender BG, Ikle DN, DuHamel T, Tinkelman D. Neuropsychological and behavioral changes in asthmatic children treated with beclomethasone dipropionate versus theophylline. Pediatrics. 1998;101:355–60.CrossRefPubMed Bender BG, Ikle DN, DuHamel T, Tinkelman D. Neuropsychological and behavioral changes in asthmatic children treated with beclomethasone dipropionate versus theophylline. Pediatrics. 1998;101:355–60.CrossRefPubMed
29.
go back to reference Bratek A, Zawada K, Barczyk A, Sozanska E, Krysta K. Analysis of psychoemotional state and intellectual abilities in patients with asthma and chronic obstructive pulmonary disease - preliminary results. Psychiatr Danub. 2013;25:S207–11.PubMed Bratek A, Zawada K, Barczyk A, Sozanska E, Krysta K. Analysis of psychoemotional state and intellectual abilities in patients with asthma and chronic obstructive pulmonary disease - preliminary results. Psychiatr Danub. 2013;25:S207–11.PubMed
30.
go back to reference Flannery KA, Liederman J. Is there really a syndrome involving the co-occurrence of neurodevelopmental disorder talent, non-right handedness and immune disorder among children? Cortex. 1995;31:503–15.CrossRefPubMed Flannery KA, Liederman J. Is there really a syndrome involving the co-occurrence of neurodevelopmental disorder talent, non-right handedness and immune disorder among children? Cortex. 1995;31:503–15.CrossRefPubMed
31.
go back to reference Lindgren S, Lokshin B, Stromquist A, Weinberger M, Nassif E, McCubbin M, et al. Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med. 1992;327:926–30.CrossRefPubMed Lindgren S, Lokshin B, Stromquist A, Weinberger M, Nassif E, McCubbin M, et al. Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med. 1992;327:926–30.CrossRefPubMed
32.
go back to reference Annett RD, Bender BG. Neuropsychological dysfunction in asthmatic children. Neuropsychol Rev. 1994;4:91–115.CrossRefPubMed Annett RD, Bender BG. Neuropsychological dysfunction in asthmatic children. Neuropsychol Rev. 1994;4:91–115.CrossRefPubMed
33.
go back to reference Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–85.CrossRefPubMed Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–85.CrossRefPubMed
34.
go back to reference Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thoracic Soc. 2007;4:522–5.CrossRef Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thoracic Soc. 2007;4:522–5.CrossRef
35.
go back to reference Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099–107.CrossRefPubMed Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099–107.CrossRefPubMed
36.
go back to reference Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med. 2012;186:11–6.CrossRefPubMed Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med. 2012;186:11–6.CrossRefPubMed
37.
go back to reference Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12:634–41.CrossRefPubMed Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12:634–41.CrossRefPubMed
39.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRefPubMed Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRefPubMed
40.
go back to reference Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–9.CrossRefPubMed Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–9.CrossRefPubMed
41.
go back to reference Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1982;142:1470–6.CrossRef Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1982;142:1470–6.CrossRef
42.
go back to reference Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest J. 2013;144:119–27.CrossRef Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest J. 2013;144:119–27.CrossRef
43.
go back to reference Antonelli I, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, et al. Drawing impairment predicts mortality in severe COPD [see comment]. Chest. 2006;130:1687–94.CrossRef Antonelli I, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, et al. Drawing impairment predicts mortality in severe COPD [see comment]. Chest. 2006;130:1687–94.CrossRef
44.
go back to reference Zarowitz BJ, O'Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012;18:598–606.PubMed Zarowitz BJ, O'Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012;18:598–606.PubMed
45.
go back to reference Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch General Psychiatry. 1987;44:999–1006.CrossRef Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch General Psychiatry. 1987;44:999–1006.CrossRef
46.
go back to reference Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:134–7.CrossRefPubMed Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:134–7.CrossRefPubMed
47.
go back to reference Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.CrossRefPubMed Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.CrossRefPubMed
48.
go back to reference Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71:581–8.CrossRefPubMedCentralPubMed Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71:581–8.CrossRefPubMedCentralPubMed
49.
go back to reference Kozora E, Filley CM, Julian LJ, Cullum CM. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:178–83.PubMed Kozora E, Filley CM, Julian LJ, Cullum CM. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:178–83.PubMed
50.
go back to reference Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996;8:113–25.CrossRefPubMed Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996;8:113–25.CrossRefPubMed
51.
go back to reference Petiet CA, Townes BD, Brooks RJ, Kramer JH. Neurobehavioral and psychosocial functioning of women exposed to high altitude in mountaineering. Perceptual Motor Skills. 1988;67:443–52.CrossRefPubMed Petiet CA, Townes BD, Brooks RJ, Kramer JH. Neurobehavioral and psychosocial functioning of women exposed to high altitude in mountaineering. Perceptual Motor Skills. 1988;67:443–52.CrossRefPubMed
52.
go back to reference Noble J, Jones JG, Davis EJ. Cognitive function during moderate hypoxaemia. Anaesth Intensive Care. 1993;21:180–4.PubMed Noble J, Jones JG, Davis EJ. Cognitive function during moderate hypoxaemia. Anaesth Intensive Care. 1993;21:180–4.PubMed
53.
go back to reference van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM. Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment. J Psychopharmacol. 2002;16:337–43.CrossRefPubMed van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM. Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment. J Psychopharmacol. 2002;16:337–43.CrossRefPubMed
54.
go back to reference Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1983;143:1941–7.CrossRef Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1983;143:1941–7.CrossRef
55.
go back to reference Lahousse L, Vernooij MW, Darweesh SKL, Akoudad S, Loth DW, Joos GF, et al. Chronic obstructive pulmonary disease and cerebral microbleeds: The Rotterdam Study. Am J Respir Crit Care Med. 2013;188:783–8.CrossRefPubMed Lahousse L, Vernooij MW, Darweesh SKL, Akoudad S, Loth DW, Joos GF, et al. Chronic obstructive pulmonary disease and cerebral microbleeds: The Rotterdam Study. Am J Respir Crit Care Med. 2013;188:783–8.CrossRefPubMed
56.
go back to reference Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease. A multi-modal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–5.CrossRefPubMed Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease. A multi-modal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–5.CrossRefPubMed
57.
go back to reference Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med. 2004;128:32–8.PubMed Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med. 2004;128:32–8.PubMed
58.
go back to reference Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652–60.CrossRefPubMedCentralPubMed Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652–60.CrossRefPubMedCentralPubMed
59.
go back to reference Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, et al. Arterial stiffness and cerebral small vessel disease: The Rotterdam Scan Study. Stroke. 2012;43:2637–42.CrossRefPubMed Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, et al. Arterial stiffness and cerebral small vessel disease: The Rotterdam Scan Study. Stroke. 2012;43:2637–42.CrossRefPubMed
60.
go back to reference Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1259–65.CrossRefPubMed Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1259–65.CrossRefPubMed
61.
go back to reference McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208–14.CrossRefPubMedCentralPubMed McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208–14.CrossRefPubMedCentralPubMed
62.
go back to reference Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest J. 2013;143:798–807.CrossRef Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest J. 2013;143:798–807.CrossRef
63.
go back to reference Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29:527–34.CrossRefPubMed Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29:527–34.CrossRefPubMed
64.
go back to reference Buckingham RJ, Lowe D, Pursey NA, Roberts CM, Stone RA. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Clinical Audit of the COPD exacerbations admitted to acute NHS units across the UK. London: Royal College of Physicians - Clinical Effectiveness & Evaluation Unit, British Thoracic Society, British Lung Foundation; 2008. Buckingham RJ, Lowe D, Pursey NA, Roberts CM, Stone RA. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Clinical Audit of the COPD exacerbations admitted to acute NHS units across the UK. London: Royal College of Physicians - Clinical Effectiveness & Evaluation Unit, British Thoracic Society, British Lung Foundation; 2008.
65.
go back to reference Patel ARC, Kowlessar BS, Donaldson GC, Mackay AJ, Singh R, George SN, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:1091–9.CrossRefPubMedCentralPubMed Patel ARC, Kowlessar BS, Donaldson GC, Mackay AJ, Singh R, George SN, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:1091–9.CrossRefPubMedCentralPubMed
66.
go back to reference Domino EF. Tobacco smoking and MRI/MRS brain abnormalities compared to nonsmokers. Prog Neuro-psychopharmacol Biol Psychiatry. 2008;32:1778–81.CrossRef Domino EF. Tobacco smoking and MRI/MRS brain abnormalities compared to nonsmokers. Prog Neuro-psychopharmacol Biol Psychiatry. 2008;32:1778–81.CrossRef
67.
go back to reference Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17:259–73.CrossRefPubMed Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17:259–73.CrossRefPubMed
68.
go back to reference Liao D, Higgins M, Bryan NR, Eigenbrodt ML, Chambless LE, Lamar V, et al. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study. Chest. 1999;116:150–6.CrossRefPubMed Liao D, Higgins M, Bryan NR, Eigenbrodt ML, Chambless LE, Lamar V, et al. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study. Chest. 1999;116:150–6.CrossRefPubMed
69.
go back to reference Longstreth Jr WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study Stroke. 1996;27:1274–82. Longstreth Jr WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study Stroke. 1996;27:1274–82.
70.
go back to reference Ding JZ, Nieto FJ, Beauchamp NJ, Longstreth WT, Manolio TA, Hetmanski JB, et al. A prospective analysis of risk factors for white matter disease in the brain stem. Neuroepidemiology. 2003;22:275–82.CrossRefPubMed Ding JZ, Nieto FJ, Beauchamp NJ, Longstreth WT, Manolio TA, Hetmanski JB, et al. A prospective analysis of risk factors for white matter disease in the brain stem. Neuroepidemiology. 2003;22:275–82.CrossRefPubMed
71.
go back to reference Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke, The Copenhagen City Heart Study. Int J Epidemiol. 2001;30:145–51.CrossRefPubMed Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke, The Copenhagen City Heart Study. Int J Epidemiol. 2001;30:145–51.CrossRefPubMed
72.
go back to reference Sachdev PS, Anstey KJ, Parslow RA, Wen W, Maller J, Kumar R, et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord. 2006;21:300–8.CrossRefPubMed Sachdev PS, Anstey KJ, Parslow RA, Wen W, Maller J, Kumar R, et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord. 2006;21:300–8.CrossRefPubMed
73.
74.
go back to reference Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. Am J Neuroradiol. 2013;34:334–9.CrossRefPubMed Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. Am J Neuroradiol. 2013;34:334–9.CrossRefPubMed
75.
go back to reference van Dijk EJ, Vermeer SE, de Groot JC, van de Minkelis J, Prins ND, Oudkerk M, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75:733–6.CrossRefPubMedCentralPubMed van Dijk EJ, Vermeer SE, de Groot JC, van de Minkelis J, Prins ND, Oudkerk M, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75:733–6.CrossRefPubMedCentralPubMed
76.
go back to reference Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, et al. Modeling the impact of COPD on the brain. Int J COPD. 2008;3:429–34. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, et al. Modeling the impact of COPD on the brain. Int J COPD. 2008;3:429–34.
77.
go back to reference Charlton RA, Barrick TR, Lawes IN, Markus HS, Morris RG. White matter pathways associated with working memory in normal aging. Cortex. 2010;46:474–89.CrossRefPubMed Charlton RA, Barrick TR, Lawes IN, Markus HS, Morris RG. White matter pathways associated with working memory in normal aging. Cortex. 2010;46:474–89.CrossRefPubMed
78.
go back to reference Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case–control study. BMJ Open. 2012;2:e000844.CrossRefPubMedCentralPubMed Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case–control study. BMJ Open. 2012;2:e000844.CrossRefPubMedCentralPubMed
79.
go back to reference Johnson NF, Kim C, Clasey JL, Bailey A, Gold BT. Cardiorespiratory fitness is positively correlated with cerebral white matter integrity in healthy seniors. Neuroimage. 2012;59:1514–23.CrossRefPubMedCentralPubMed Johnson NF, Kim C, Clasey JL, Bailey A, Gold BT. Cardiorespiratory fitness is positively correlated with cerebral white matter integrity in healthy seniors. Neuroimage. 2012;59:1514–23.CrossRefPubMedCentralPubMed
80.
go back to reference Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest. 2001;120:1506–13.CrossRefPubMed Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest. 2001;120:1506–13.CrossRefPubMed
81.
go back to reference Guo RB, Sun PL, Zhao AP, Gu J, Ding X, Qi J, et al. Chronic asthma results in cognitive dysfunction in immature mice. Exp Neurol. 2013;247:209–17.CrossRefPubMed Guo RB, Sun PL, Zhao AP, Gu J, Ding X, Qi J, et al. Chronic asthma results in cognitive dysfunction in immature mice. Exp Neurol. 2013;247:209–17.CrossRefPubMed
82.
go back to reference Parker J, Wolansky LJ, Khatry D, Geba GP, Molfino NA. Brain magnetic resonance imaging in adults with asthma. Contemp Clin Trials. 2011;32:86–9.CrossRefPubMed Parker J, Wolansky LJ, Khatry D, Geba GP, Molfino NA. Brain magnetic resonance imaging in adults with asthma. Contemp Clin Trials. 2011;32:86–9.CrossRefPubMed
84.
go back to reference Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol. 1996;143:750–6.CrossRefPubMed Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol. 1996;143:750–6.CrossRefPubMed
85.
go back to reference Ryu CW, Jahng GH, Choi CW, Rhee HY, Kim MJ, Kim SM, et al. Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRI. COPD. 2013;10:357–66.CrossRefPubMed Ryu CW, Jahng GH, Choi CW, Rhee HY, Kim MJ, Kim SM, et al. Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRI. COPD. 2013;10:357–66.CrossRefPubMed
Metadata
Title
Lung disease as a determinant of cognitive decline and dementia
Author
James W Dodd
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Alzheimer's Research & Therapy / Issue 1/2015
Electronic ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-015-0116-3

Other articles of this Issue 1/2015

Alzheimer's Research & Therapy 1/2015 Go to the issue